Epigenomic Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: EC579EEB4B98EN
Market Monitor Global

Abstracts

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.

This report contains market size and forecasts of Epigenomic in Global, including the following market information:

Global Epigenomic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Epigenomic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Reagents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Epigenomic include Roche Diagnostics, Thermo Fisher Scientific, Eisai and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenomic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epigenomic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Epigenomic Market Segment Percentages, by Type, 2021 (%)

• Reagents
• Kits
• Instruments
• Services

Global Epigenomic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Epigenomic Market Segment Percentages, by Application, 2021 (%)

• Research Institution
• Hospital
• Others

Global Epigenomic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Epigenomic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Epigenomic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Epigenomic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche Diagnostics
• Thermo Fisher Scientific
• Eisai
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Epigenomic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Epigenomic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPIGENOMIC OVERALL MARKET SIZE

2.1 Global Epigenomic Market Size: 2021 VS 2028
2.2 Global Epigenomic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Epigenomic Players in Global Market
3.2 Top Global Epigenomic Companies Ranked by Revenue
3.3 Global Epigenomic Revenue by Companies
3.4 Top 3 and Top 5 Epigenomic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Epigenomic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epigenomic Players in Global Market
  3.6.1 List of Global Tier 1 Epigenomic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Epigenomic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Epigenomic Market Size Markets, 2021 & 2028
  4.1.2 Reagents
  4.1.3 Kits
  4.1.4 Instruments
  4.1.5 Services
4.2 By Type - Global Epigenomic Revenue & Forecasts
  4.2.1 By Type - Global Epigenomic Revenue, 2017-2022
  4.2.2 By Type - Global Epigenomic Revenue, 2023-2028
  4.2.3 By Type - Global Epigenomic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Epigenomic Market Size, 2021 & 2028
  5.1.2 Research Institution
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Epigenomic Revenue & Forecasts
  5.2.1 By Application - Global Epigenomic Revenue, 2017-2022
  5.2.2 By Application - Global Epigenomic Revenue, 2023-2028
  5.2.3 By Application - Global Epigenomic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Epigenomic Market Size, 2021 & 2028
6.2 By Region - Global Epigenomic Revenue & Forecasts
  6.2.1 By Region - Global Epigenomic Revenue, 2017-2022
  6.2.2 By Region - Global Epigenomic Revenue, 2023-2028
  6.2.3 By Region - Global Epigenomic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Epigenomic Revenue, 2017-2028
  6.3.2 US Epigenomic Market Size, 2017-2028
  6.3.3 Canada Epigenomic Market Size, 2017-2028
  6.3.4 Mexico Epigenomic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Epigenomic Revenue, 2017-2028
  6.4.2 Germany Epigenomic Market Size, 2017-2028
  6.4.3 France Epigenomic Market Size, 2017-2028
  6.4.4 U.K. Epigenomic Market Size, 2017-2028
  6.4.5 Italy Epigenomic Market Size, 2017-2028
  6.4.6 Russia Epigenomic Market Size, 2017-2028
  6.4.7 Nordic Countries Epigenomic Market Size, 2017-2028
  6.4.8 Benelux Epigenomic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Epigenomic Revenue, 2017-2028
  6.5.2 China Epigenomic Market Size, 2017-2028
  6.5.3 Japan Epigenomic Market Size, 2017-2028
  6.5.4 South Korea Epigenomic Market Size, 2017-2028
  6.5.5 Southeast Asia Epigenomic Market Size, 2017-2028
  6.5.6 India Epigenomic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Epigenomic Revenue, 2017-2028
  6.6.2 Brazil Epigenomic Market Size, 2017-2028
  6.6.3 Argentina Epigenomic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Epigenomic Revenue, 2017-2028
  6.7.2 Turkey Epigenomic Market Size, 2017-2028
  6.7.3 Israel Epigenomic Market Size, 2017-2028
  6.7.4 Saudi Arabia Epigenomic Market Size, 2017-2028
  6.7.5 UAE Epigenomic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche Diagnostics
  7.1.1 Roche Diagnostics Corporate Summary
  7.1.2 Roche Diagnostics Business Overview
  7.1.3 Roche Diagnostics Epigenomic Major Product Offerings
  7.1.4 Roche Diagnostics Epigenomic Revenue in Global Market (2017-2022)
  7.1.5 Roche Diagnostics Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific Epigenomic Major Product Offerings
  7.2.4 Thermo Fisher Scientific Epigenomic Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 Eisai
  7.3.1 Eisai Corporate Summary
  7.3.2 Eisai Business Overview
  7.3.3 Eisai Epigenomic Major Product Offerings
  7.3.4 Eisai Epigenomic Revenue in Global Market (2017-2022)
  7.3.5 Eisai Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Epigenomic Major Product Offerings
  7.4.4 Novartis Epigenomic Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Epigenomic Market Opportunities & Trends in Global Market
Table 2. Epigenomic Market Drivers in Global Market
Table 3. Epigenomic Market Restraints in Global Market
Table 4. Key Players of Epigenomic in Global Market
Table 5. Top Epigenomic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Epigenomic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Epigenomic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Epigenomic Product Type
Table 9. List of Global Tier 1 Epigenomic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epigenomic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Epigenomic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Epigenomic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Epigenomic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Epigenomic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Epigenomic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Epigenomic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Epigenomic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Epigenomic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Epigenomic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Epigenomic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Epigenomic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Epigenomic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Epigenomic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Epigenomic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Epigenomic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Epigenomic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Epigenomic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Epigenomic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Epigenomic Revenue, (US$, Mn), 2023-2028
Table 30. Roche Diagnostics Corporate Summary
Table 31. Roche Diagnostics Epigenomic Product Offerings
Table 32. Roche Diagnostics Epigenomic Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific Epigenomic Product Offerings
Table 35. Thermo Fisher Scientific Epigenomic Revenue (US$, Mn), (2017-2022)
Table 36. Eisai Corporate Summary
Table 37. Eisai Epigenomic Product Offerings
Table 38. Eisai Epigenomic Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Epigenomic Product Offerings
Table 41. Novartis Epigenomic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Epigenomic Segment by Type in 2021
Figure 2. Epigenomic Segment by Application in 2021
Figure 3. Global Epigenomic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Epigenomic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Epigenomic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epigenomic Revenue in 2021
Figure 8. By Type - Global Epigenomic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Epigenomic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Epigenomic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Epigenomic Revenue Market Share, 2017-2028
Figure 12. US Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Epigenomic Revenue Market Share, 2017-2028
Figure 16. Germany Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 17. France Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Epigenomic Revenue Market Share, 2017-2028
Figure 24. China Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 28. India Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Epigenomic Revenue Market Share, 2017-2028
Figure 30. Brazil Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Epigenomic Revenue Market Share, 2017-2028
Figure 33. Turkey Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Epigenomic Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Diagnostics Epigenomic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific Epigenomic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eisai Epigenomic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Epigenomic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)